Aromadendrin attenuates dexamethasone-induced osteoporosis in rats by modulating oxidative stress, inflammation, and bone remodeling.

Authors

Ru Ma, Xia Li, Mohd Afiq Muhamed Fuad, Shuang Lu

Published in

Indian journal of pharmacology. Volume 58. Issue 6. Pages 652-664. Nov 01, 2026. Epub Nov 02, 2026.

Abstract

Glucocorticoids (GCs) are used in the treatment of asthma, autoimmune and allergic disease, but long-term GC therapy increased the bone resorption, oxidative stress, inflammation, and impaired bone formation. Aromadendrin is a flavonol (flavonoid) exhibited the potent effect against oxidative stress and inflammatory disease. The aim of the experimental study was to investigate the antiosteoporosis effect of aromadendrin against dexamethasone (DEX) induced osteoporosis (OS) in the rats.
Female Sprague Dawley rats were used in this study and subcutaneous administration of DEX (2.5 mg/kg/day) was used for the induction of OS in the rats. The rats were received the oral administration of aromadendrin (2.5, 5 and 10 mg/kg) and alendronate for 20 weeks. The body weight, organ weight, transverse diameter, bone length, microcomputed tomography (MicroCT) parameters, oxidative stress parameters, inflammatory cytokines, caspase parameters, inflammatory parameters and messenger ribonucleic acid (mRNA) expression were estimated.
Aromadendrin treatment improved the body weight and altered the organ weight (vagina, uterus, and femoral weight); bone weight, transverse diameter, bine length, bone mineral density and bone mineral content level. Aromadendrin altered the level of MicroCT parameters, bone parameters (osteocalcin [OC], border gateway protocol, tartrate-resistant acid phosphatase, beta-CrossLaps, alkaline phosphatase, acid phosphatase); nutrient (phosphorus, magnesium, calcium, 1,25(OH)2-vitamin D3); hormone level (calcitonin, parathyroid hormone, E2), oxidative stress, inflammatory cytokines, inflammatory parameters (nuclear factor-κB [NF-κB], C-reactive protein, monocyte chemoattractant protein-1); caspase parameters (caspase-3, caspase-8, caspase-9), receptor activator of nuclear factor B ligand (RANKL), Osteoprotegerin (OPG), and OPG/RANKL ratio, respectively. Aromadendrin treatment altered the mRNA expression of RANKL, OPG, OPG/RANKL ratio.
Aromadendrin exerts an anti-OS effect against DEX-induced OS in rats via alteration of NF-κB and RANKL/OPG signaling pathway.

PMID:
42969984
Bibliographic data and abstract were imported from PubMed on 02 Nov 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.